William Farley
Direktor/Vorstandsmitglied bei GLOBESTAR THERAPEUTICS CORPORATION
Vermögen: - $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von William Farley
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA.
21
| Subsidiary | Pharmaceuticals: Major | 21 |
| Public Company | Pharmaceuticals: Major | 17 | |
| Public Company | Biotechnology | 12 | |
| Public Company | Biotechnology | 5 | |
ChemDiv, Inc.
 ChemDiv, Inc. Miscellaneous Commercial ServicesCommercial Services ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von William Farley
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer General Counsel | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Public Communications Contact Director of Finance/CFO | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TALISKER RESOURCES LTD. | Precious Metals | Director/Board Member Chief Executive Officer Corporate Secretary | |
| CGX ENERGY INC. | Oil & Gas Production | Director of Finance/CFO Public Communications Contact | |
| CARDIOCOMM SOLUTIONS, INC. | Packaged Software | Director/Board Member | |
| GRANDE PORTAGE RESOURCES LTD. | Precious Metals | Chief Executive Officer | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Zacoro Metals Corp.
 Zacoro Metals Corp. Precious MetalsNon-Energy Minerals Zacoro Metals Corp. mines and explores for gold and other metals. It engages in the mining of copper, gold, and zinc. The company is located in Toronto, Canada | Precious Metals | Director of Finance/CFO Corporate Secretary | |
| GMV MINERALS INC. | Precious Metals | Chief Executive Officer | |
| NANO MOBILE HEALTHCARE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Director/Board Member | |
| VIREXIT TECHNOLOGIES, INC. | Biotechnology | Chief Executive Officer Sales & Marketing | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member General Counsel | |
University of Pittsburgh Medical Center
 University of Pittsburgh Medical Center Medical/Nursing ServicesHealth Services University of Pittsburgh Medical Center is a non-profit organization, which engages in the provision of hospital health programs and services. It operates through the following business units: Provider Services, Insurance Services, UPMC International, and UPMC Enterprises. It also develops programs in transplantation, cancer, neurosurgery, psychiatry, orthopedics, and sports medicine. The company was founded in 1893 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Corporate Officer/Principal | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Compliance Officer | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree | |
| FORRESTER METALS INC | Other Metals/Minerals | Director/Board Member Investor Relations Contact | |
| St. Joseph's University | College/University | Masters Business Admin Masters Business Admin | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Arizona | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
Trelawney Mining & Exploration, Inc.
 Trelawney Mining & Exploration, Inc. Precious MetalsNon-Energy Minerals Trelawney Mining & Exploration, Inc. mines for gold and other miscellaneous minerals. The firm's current focus is the exploration and development of the Côté Lake Gold Deposit in the Swayze Greenstone Belt, located halfway between Timmins and Sudbury. The company was founded on July 4, 1996 and is headquartered in Toronto, Canada. | Precious Metals | Director/Board Member Corporate Secretary | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University College London | College/University | Doctorate Degree Undergraduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| SCILEX HOLDING COMPANY | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer Director of Finance/CFO Director/Board Member Chairman Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Chairman Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| VIRPAX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
| Fudan University | College/University | Undergraduate Degree Undergraduate Degree | |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree Corporate Officer/Principal | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| TALPHERA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
Kalgene Pharmaceuticals, Inc.
 Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Kalgene Pharmaceuticals, Inc. develops and focuses on personalized cancer diagnostics and drugs. It offers drugs for epithelial and thyroid cancers. The firm's oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on bladder, epithelial and thyroid cancers. It serves the biopharmaceutical, research and development and health industries. The company is headquartered in Kingston, Canada. | Medical/Nursing Services | Chairman |
Statistik
International
| Vereinigte Staaten | 28 |
| Kanada | 16 |
| Vereinigtes Königreich | 3 |
| Schweiz | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 11 |
| Non-Energy Minerals | 7 |
| Finance | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 247 |
| Corporate Officer/Principal | 107 |
| Independent Dir/Board Member | 82 |
| Director of Finance/CFO | 66 |
| Chief Executive Officer | 56 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jim Fairbairn | 45 |
| Mohsin Meghji | 37 |
| Mahendra Shah | 34 |
| Elizabeth Czerepak | 32 |
| Brent Ahrens | 30 |
| Paul van Damme | 26 |
| David Lemus | 22 |
| Anthony Giovinazzo | 22 |
| Eric Floyd | 20 |
| Scott Whitcup | 18 |
| Jaisim Shah | 17 |
| George Ng | 17 |
| Henry Ji | 17 |
| Yue Wu | 16 |
| Laura Hamill | 15 |
- Börse
- Insiders
- William Farley
- Unternehmensverbindungen
